Fresh Tracks Therapeutics: Q2 Earnings Snapshot

BOULDER, Colo. (AP) — BOULDER, Colo. (AP) — Fresh Tracks Therapeutics, Inc. (FRTX) on Friday reported a loss of $2.3 million in its second quarter.

The Boulder, Colorado-based company said it had a loss of 39 cents per share.

The drug developer posted revenue of $53,000 in the period.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on FRTX at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up